156 related articles for article (PubMed ID: 22619383)
21. Valproate-induced hyperammonemic encephalopathy.
Bhatia H; Raman PG
J Assoc Physicians India; 2005 Feb; 53():158. PubMed ID: 15847043
[No Abstract] [Full Text] [Related]
22. Valproate-induced hyperammonemic encephalopathy associated with urinary tract infection and urinary retention in the psychiatric setting.
Dawson LP; Lee SJ; Hollander YS
Aust N Z J Psychiatry; 2016 Nov; 50(11):1110. PubMed ID: 27056174
[No Abstract] [Full Text] [Related]
23. Valproic acid-induced myopathy in a patient with schizoaffective disorder.
Reiche I; Tröger U; Postel SC; Wolf R; Bode-Böger SM
J Clin Psychopharmacol; 2009 Aug; 29(4):402-3. PubMed ID: 19593189
[No Abstract] [Full Text] [Related]
24. Valproate-induced reversible pseudoatrophy of the brain and hyperammonemic encephalopathy in a bipolar patient.
Abreu LN; Issler C; Lafer B
Aust N Z J Psychiatry; 2009 May; 43(5):484-5. PubMed ID: 19382315
[No Abstract] [Full Text] [Related]
25. Valproate-induced encephalopathy related to concurrent antimanic medications.
Trojak B; de la Gastine B; Dollfus S
J Neuropsychiatry Clin Neurosci; 2011; 23(1):E22-3. PubMed ID: 21304120
[No Abstract] [Full Text] [Related]
26. Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report.
Patel N; Landry KB; Fargason RE; Birur B
Psychopharmacol Bull; 2017 Jan; 47(1):40-44. PubMed ID: 28138203
[TBL] [Abstract][Full Text] [Related]
27. Valproate-induced hyperammonemic encephalopathy: a case report and brief review of the literature.
Sunkavalli KK; Iqbal FM; Singh B; Koneru J
Am J Ther; 2013; 20(5):569-71. PubMed ID: 21248614
[TBL] [Abstract][Full Text] [Related]
28. Noncirrhotic hyperammonaemic encephalopathy.
Laish I; Ben Ari Z
Liver Int; 2011 Oct; 31(9):1259-70. PubMed ID: 21745294
[TBL] [Abstract][Full Text] [Related]
29. [Encephalopathy associated with hyperammonemia in an alcoholic patient treated with sodium valproate].
Mattei A; Bernard G; Plauchu G; Paliard P
Gastroenterol Clin Biol; 1993; 17(6-7):516-7. PubMed ID: 8243949
[No Abstract] [Full Text] [Related]
30. Valproate-induced hyperammonemic encephalopathy followed by benzodiazepine withdrawal in a patient with schizoaffective disorder: a differential diagnosis.
Sarlon J; Hess E; Krasnianski A
J Neuropsychiatry Clin Neurosci; 2013; 25(3):E69-70. PubMed ID: 24026753
[No Abstract] [Full Text] [Related]
31. Valproate-induced hyperammonaemia.
Raja M; Azzoni A
J Clin Psychopharmacol; 2002 Dec; 22(6):631-3. PubMed ID: 12454569
[No Abstract] [Full Text] [Related]
32. Valproate-induced hyperammonemic encephalopathy: a case report.
Shah S; Wang R; Vieux U
J Med Case Rep; 2020 Jan; 14(1):19. PubMed ID: 31980035
[TBL] [Abstract][Full Text] [Related]
33. Valproic acid-induced hyperammonemia and minimal hepatic encephalopathy prevalence among psychiatric inpatients.
Thomas KL; La AQ; Punia S; Doroudgar S; Perry PJ
Ann Clin Psychiatry; 2016 Feb; 28(1):37-42. PubMed ID: 26855984
[TBL] [Abstract][Full Text] [Related]
34. Valproate-induced hyperammonemic encephalopathy, rapidly improved by i.v. carnitine and glucose/thiamine.
Bøhmer T; Bøen A; Høymork SC
Scand J Gastroenterol; 2010 Jun; 45(6):762-3. PubMed ID: 20163200
[No Abstract] [Full Text] [Related]
35. [Report of three cases of hyperammonaemic encephalopathy associated with valproic acid due to possible synergism with phenobarbital and topiramate].
Cano-Zuleta A; Hernández-Ortíz OH; González-González CA; Amariles P
Farm Hosp; 2012; 36(5):441-2. PubMed ID: 22266198
[No Abstract] [Full Text] [Related]
36. Extracorporeal Liver Support for the Treatment of Hyperammonemia After Lung Transplantation.
Kwon M; Alvarez F; Moreno Franco P; Patel A; Canabal JM; Haddad TJ; Erasmus DB; Mallea JM; Narula T
Transplantation; 2020 Mar; 104(3):e75-e76. PubMed ID: 31385932
[No Abstract] [Full Text] [Related]
37. Hyperammonemia associated with valproic acid use in elderly psychiatric patients.
Holroyd S; Overdyke JT
J Neuropsychiatry Clin Neurosci; 2012; 24(3):372-4. PubMed ID: 23037652
[TBL] [Abstract][Full Text] [Related]
38. Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.
Velioğlu SK; Gazioğlu S
Acta Neurol Scand; 2007 Aug; 116(2):128-32. PubMed ID: 17661800
[TBL] [Abstract][Full Text] [Related]
39. Valproate-induced hyperammonaemia superimposed upon severe neuropsychiatric lupus: a case report and review of the literature.
Chan E; McQueen F
Clin Rheumatol; 2013 Mar; 32(3):403-7. PubMed ID: 23271612
[TBL] [Abstract][Full Text] [Related]
40. Cervical dystonia due to interaction of valproic acid and quetiapine.
Habermeyer B; Rabovsky K; Jentzsch C; Pinhard K; Müller-Spahn F
J Clin Psychopharmacol; 2007 Aug; 27(4):396-7. PubMed ID: 17632227
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
